MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MINKEL, D. T.
Right arrow Articles by PETERING, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MINKEL, D. T.
Right arrow Articles by PETERING, D. H.

Molecular Pharmacology, Vol 12, 1036-1044, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

Reactions of 3-Ethoxy-2-oxobutyraldehyde Bis(N4-dimethylthiosemicarbazonato)-Zinc(II) with Tumor Cells and Mitochondria

DANIEL T. MINKEL 1, CHRISTINE CHAN-STIER 1, and DAVID H. PETERING 1

1 Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201

Physicochemical and biological properties of bis(thiosemicarbazonato)-zinc complexes have been investigated. Respiration of Ehrlich ascites cells is inhibited by 3-ethoxy-2-oxobutyraldehyde bis(N4-dimethylthiosemicarbazonato)-zinc(II). Zinc ion is much less effective, but the thiosemicarbazone ligand initially stimulates, then depresses, oxygen uptake. State 3 oxygen uptake of tumor cell mitochondria is more sensitive to this zinc complex than is state 4. In bovine heart mitochondria respiratory inhibition occurs almost exclusively in state 3. The insensitivity of the electron transport chain to the complex was confirmed with Keilin-Hartree particles. Formation constants and partition coefficients for several bis(thiosemicarbazonato)-zinc complexes are used to interpret the different behavior of zinc ion, thiosemicarbazone ligand, and zinc complex with tumor cells and mitochondria.

Submitted on December 30, 1975
Accepted on July 14, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics